10-Q: Quarterly report pursuant to Section 13 or 15(d)
Published on November 3, 2022
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or |
(Commission file number) |
(IRS Employer Identification No.) |
(Address of principal executive offices)
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Accelerated filer ◻ |
Non-accelerated filer ◻ |
Smaller reporting company |
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes |
No ☒ |
As of October 31, 2022, there were
OMEGA HEALTHCARE INVESTORS, INC.
FORM 10-Q
September 30, 2022
TABLE OF CONTENTS | ||
Page |
||
2 |
||
3 |
||
4 |
||
5 |
||
7 |
||
8 |
||
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
35 |
|
53 |
||
53 |
||
53 |
||
53 |
||
54 |
||
55 |
PART I – FINANCIAL INFORMATION
Item 1 - Financial Statements
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
|
September 30, |
|
December 31, |
|||
|
2022 |
|
2021 |
|||
(Unaudited) |
||||||
ASSETS |
||||||
Real estate assets |
|
|
|
|
||
Buildings and improvements |
$ |
|
|
$ |
|
|
Land |
|
|
||||
Furniture and equipment |
|
|
||||
Construction in progress |
|
|
||||
Total real estate assets |
|
|
||||
Less accumulated depreciation |
|
( |
|
|
( |
|
Real estate assets – net |
|
|
|
|
|
|
Investments in direct financing leases – net |
|
|
|
|
|
|
Mortgage notes receivable – net |
|
|
|
|
|
|
|
|
|||||
Other investments – net |
|
|
|
|
|
|
Investments in unconsolidated joint ventures |
|
|
|
|
|
|
Assets held for sale |
|
|
|
|
|
|
Total investments |
|
|
|
|
|
|
Cash and cash equivalents |
|
|
|
|
|
|
Restricted cash |
|
|
|
|
|
|
Contractual receivables – net |
|
|
|
|
|
|
Other receivables and lease inducements |
|
|
||||
Goodwill |
|
|
|
|
|
|
Other assets |
|
|
|
|
|
|
Total assets |
$ |
|
|
$ |
|
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
Revolving credit facility |
$ |
|
|
$ |
— |
|
Secured borrowings |
|
|
|
|
|
|
Senior notes and other unsecured borrowings – net |
|
|
|
|
|
|
Accrued expenses and other liabilities |
|
|
|
|
|
|
Total liabilities |
|
|
|
|
|
|
Equity: |
|
|
|
|
||
Preferred stock $ |
||||||
Common stock $ |
|
|
|
|
||
Additional paid-in capital |
|
|
|
|
||
Cumulative net earnings |
|
|
|
|
||
Cumulative dividends paid |
|
( |
|
( |
||
Accumulated other comprehensive income (loss) |
|
|
|
( |
||
Total stockholders’ equity |
|
|
|
|
||
Noncontrolling interest |
|
|
|
|
||
Total equity |
|
|
|
|
||
Total liabilities and equity |
$ |
|
|
$ |
|
See notes to consolidated financial statements.
2
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)
|
Three Months Ended |
Nine Months Ended |
|
|||||||||||
|
September 30, |
|
September 30, |
|||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
||||||
Revenues |
||||||||||||||
Rental income |
$ |
|
$ |
|
|
$ |
|
$ |
|
|||||
Income from direct financing leases |
|
|
|
|
|
|
|
|
|
|||||
Mortgage interest income |
|
|
|
|
|
|
|
|
|
|||||
Other investment income |
|
|
|
|
|
|
|
|
|
|||||
Miscellaneous income |
|
|
|
|
|
|
|
|
|
|||||
Total revenues |
|
|
|
|
|
|
|
|
|
|||||
Expenses |
|
|
|
|
|
|
|
|
|
|||||
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|||||
General and administrative |
|
|
|
|
|
|
|
|
|
|||||
Real estate taxes |
|
|
|
|
||||||||||
Acquisition, merger and transition related costs |
|
|
|
— |
|
|
|
|
|
|||||
Impairment on real estate properties |
|
|
|
|
|
|
|
|
|
|||||
Recovery on direct financing leases |
|
— |
|
— |
|
|
— |
|
( |
|||||
Provision for credit losses |
|
|
|
|
|
|
|
|
|
|||||
Interest expense |
|
|
|
|
|
|
|
|
|
|||||
Total expenses |
|
|
|
|
|
|
|
|
|
|||||
Other income (expense) |
|
|
|
|
|
|
|
|||||||
Other (expense) income – net |
|
( |
|
( |
|
|
( |
|
|
|||||
Loss on debt extinguishment |
|
( |
|
( |
|
|
( |
|
( |
|||||
Gain on assets sold – net |
|
|
|
|
||||||||||
Total other income |
|
|
|
|
|
|
|
|
|
|||||
Income before income tax expense and income from unconsolidated joint ventures |
|
|
|
|
|
|
|
|
|
|||||
Income tax expense |
|
( |
|
( |
|
|
( |
|
( |
|||||
Income from unconsolidated joint ventures |
|
|
|
|
|
|
|
|
|
|||||
Net income |
|
|
|
|
|
|
|
|
|
|||||
Net income attributable to noncontrolling interest |
|
( |
|
( |
|
|
( |
|
( |
|||||
Net income available to common stockholders |
$ |
|
$ |
|
|
$ |
|
$ |
|
|||||
Earnings per common share available to common stockholders: |
|
|
|
|
|
|
|
|
|
|||||
Basic: |
|
|
|
|
|
|
|
|
||||||
Net income available to common stockholders |
$ |
|
$ |
|
|
$ |
|
$ |
|
|||||
Diluted: |
|
|
|
|
|
|
|
|
|
|||||
Net income |
$ |
|
$ |
|
|
$ |
|
$ |
|
See notes to consolidated financial statements.
3
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Unaudited
(in thousands)
Three Months Ended |
Nine Months Ended |
|||||||||||
|
September 30, |
|
September 30, |
|||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
Net income |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Other comprehensive income (loss): |
|
|
|
|
|
|
||||||
Foreign currency translation |
|
( |
|
( |
|
( |
|
( |
||||
Cash flow hedges |
|
|
|
|
|
|
|
|
||||
Total other comprehensive income (loss) |
|
|
|
( |
|
|
|
|
||||
Comprehensive income |
|
|
|
|
|
|
|
|
||||
Comprehensive income attributable to noncontrolling interest |
|
( |
|
( |
|
( |
|
( |
||||
Comprehensive income attributable to common stockholders |
$ |
|
$ |
|
$ |
|
$ |
|
See notes to consolidated financial statements.
4
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF EQUITY
Three Months Ended September 30, 2022 and 2021
Unaudited
(in thousands, except per share amounts)
Accumulated |
||||||||||||||||||||||||
Common |
Additional |
Cumulative |
Cumulative |
Other |
Total |
|||||||||||||||||||
Stock |
Paid-in |
Net |
Dividends |
Comprehensive |
Stockholders’ |
Noncontrolling |
Total |
|||||||||||||||||
|
Par Value |
|
Capital |
|
Earnings |
|
Paid |
|
Income (Loss) |
|
Equity |
|
Interest |
|
Equity |
|||||||||
Balance at June 30, 2022 |
$ |
|
$ |
|
$ |
|
$ |
( |
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Stock related compensation |
— |
|
— |
— |
— |
|
— |
|
||||||||||||||||
Issuance of common stock |
|
|
— |
— |
— |
|
— |
|
||||||||||||||||
Common dividends declared ($ |
— |
— |
— |
( |
— |
( |
— |
( |
||||||||||||||||
Omega OP Units distributions |
— |
— |
— |
— |
— |
— |
( |
( |
||||||||||||||||
Capital contribution from noncontrolling interest holder in consolidated JV |
— |
— |
— |
— |
— |
— |
|
|
||||||||||||||||
Other comprehensive income |
— |
— |
— |
— |
|
|
|
|
||||||||||||||||
Net income |
— |
— |
|
— |
— |
|
|
|
||||||||||||||||
Balance at September 30, 2022 |
$ |
|
$ |
|
$ |
|
$ |
( |
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Balance at June 30, 2021 |
$ |
|
$ |
|
$ |
|
$ |
( |
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Stock related compensation |
— |
|
— |
— |
— |
|
— |
|
||||||||||||||||
Issuance of common stock |
|
|
— |
— |
— |
|
— |
|
||||||||||||||||
Common dividends declared ($ |
— |
— |
— |
( |
— |
( |
— |
( |
||||||||||||||||
Vesting/exercising of Omega OP Units |
— |
( |
— |
— |
— |
( |